Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study.
Am J Transplant
; 21(7): 2532-2542, 2021 07.
Article
en En
| MEDLINE
| ID: mdl-33289340
Palabras clave
clinical research/practice; complication: infectious; hematology/oncology; immunosuppressant -fusion proteins and monoclonal antibodies: B cell specific; infection and infectious agents - viral; infection and infectious agents - viral: Epstein-Barr Virus (EBV); infectious disease; posttransplant lymphoproliferative disorder (PTLD)
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Infecciones por Virus de Epstein-Barr
/
Trastornos Linfoproliferativos
Tipo de estudio:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Año:
2021
Tipo del documento:
Article